SHWGF (Shandong Weigao Group Medical Polymer Co) Change In Receivables: $0 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHWGF Shandong Weigao Group Medical Polymer Co Ltd SHWGF
57 GF Score
Price $0.43
GF Value $0.81
Valuation Significantly Undervalued
! 7 Warning Signs
View Full Analysis

What is Shandong Weigao Group Medical Polymer Co Change In Receivables?

Shandong Weigao Group Medical Polymer Co SHWGF 57 Change In Receivables is $0 Mil as of Dec. 2025. GuruFocus rates SHWGF with a GF Score™ of 57/100 and a GF Value™ of $0.81 (Significantly Undervalued). The stock has 7 warning signs investors should review.

Shandong Weigao Group Medical Polymer Co's change in receivables for the quarter that ended in Dec. 2025 was $0 Mil. It means Shandong Weigao Group Medical Polymer Co's Accounts Receivable stayed the same from Jun. 2025 to Dec. 2025 .

Shandong Weigao Group Medical Polymer Co's change in receivables for the fiscal year that ended in Dec. 2025 was $-11 Mil. It means Shandong Weigao Group Medical Polymer Co's Accounts Receivable increased by $11 Mil from Dec. 2024 to Dec. 2025 .

Shandong Weigao Group Medical Polymer Co's Accounts Receivable for the quarter that ended in Dec. 2025 was $1,111 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Shandong Weigao Group Medical Polymer Co's Days Sales Outstanding for the six months ended in Dec. 2025 was 211.78.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Shandong Weigao Group Medical Polymer Co's liquidation value for the six months ended in Dec. 2025 was $902 Mil.


Shandong Weigao Group Medical Polymer Co  (OTCPK:SHWGF) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Shandong Weigao Group Medical Polymer Co's Days Sales Outstanding for the quarter that ended in Dec. 2025 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=1111.269/957.639*91
=211.78

2. In Ben Graham's calculation of liquidation value, Shandong Weigao Group Medical Polymer Co's accounts receivable are only considered to be worth 75% of book value:

Shandong Weigao Group Medical Polymer Co's liquidation value for the quarter that ended in Dec. 2025 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=1342.084-1452.249+0.75 * 1111.269+0.5 * 357.092
=902

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shandong Weigao Group Medical Polymer Co Change In Receivables Related Terms


Shandong Weigao Group Medical Polymer Co Change In Receivables Historical Data

* Premium members only.

The historical data trend for Shandong Weigao Group Medical Polymer Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shandong Weigao Group Medical Polymer Co Change In Receivables Chart

Shandong Weigao Group Medical Polymer Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -40.87 -120.34 -24.35 -44.94 -10.57

Shandong Weigao Group Medical Polymer Co Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
SHWGF
57GF Score
Shandong Weigao Group Medical Polymer Co Ltd SHWGF
Change In Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shandong Weigao Group Medical Polymer Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of $0 Mil mean?
Shandong Weigao Group Medical Polymer Co (SHWGF) has a Change In Receivables of $0 Mil as of Dec. 2025. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Shandong Weigao Group Medical Polymer Co and its competitors.
Is Shandong Weigao Group Medical Polymer Co's Change In Receivables too high?
Shandong Weigao Group Medical Polymer Co's current Change In Receivables is $0 Mil. Overall, Shandong Weigao Group Medical Polymer Co has a GF Score™ of 57/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shandong Weigao Group Medical Polymer Co's Change In Receivables compare to ISRG and BDX?
Shandong Weigao Group Medical Polymer Co's Change In Receivables of $0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Medical Devices & Instruments company?
A good Change In Receivables depends on the Medical Devices & Instruments industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Shandong Weigao Group Medical Polymer Co and its competitors. Shandong Weigao Group Medical Polymer Co's current Change In Receivables is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Weigao Group Medical Polymer Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Weigao Group Medical Polymer Co (SHWGF) is currently considered Significantly Undervalued. The stock's GF Value™ is $0.81, compared to a current price of $0.43 — trading 46.4% below its estimated fair value. The current Change In Receivables is $0 Mil. Shandong Weigao Group Medical Polymer Co's overall GF Score™ is 57/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Shandong Weigao Group Medical Polymer Co (SHWGF), the current Change In Receivables is $0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shandong Weigao Group Medical Polymer Co (SHWGF) Overvalued in 2026?

Based on GuruFocus' analysis, Shandong Weigao Group Medical Polymer Co stock appears to be undervalued. The current stock price of $0.43 is trading 46.4% below its estimated GF Value™ of $0.81. GuruFocus considers Shandong Weigao Group Medical Polymer Co to be Significantly Undervalued.

Key valuation signals for SHWGF:

  • Change In Receivables: $0 Mil
  • GF Value™: $0.81 vs. price of $0.43 (46.4% below fair value)
  • GF Score™: 57/100 with 7 warning signs

No single metric tells the full story. See the SHWGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shandong Weigao Group Medical Polymer Co Business Description

Address No.1, Weigao Road, Torch Hi-tech Science Park, Shandong Province, Weihai, CHN
Shandong Weigao Group Medical Polymer Co Ltd functions in the healthcare sector in China. Its business mainly involves the research and development, production, and sale of single-use medical device products. The company's segments include Medical device products, Orthopaedic products, Interventional products, Pharma packaging products, Blood management products, and others. The company's products comprise consumables including infusion sets, syringes, medical needles, blood bags, prefilled syringes, wound management, blood sampling products; orthopedic materials, and blood purification consumables and equipment. The company operates in the People's Republic of China, the United States, Europe, the Middle East, and Africa, Asia, and others.
57GF Score

Get the complete analysis for SHWGF

Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.43
Price
$0.81
GF Value